相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma
Hans-Georg Wirsching et al.
BRAIN (2014)
Onset of secondary progressive phase and long-term evolution of multiple sclerosis
Antonio Scalfari et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome
Gijsbert J. A. Nagtegaal et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS
Evelyn Zastepa et al.
NEUROLOGY (2014)
Fluctuations of MS births and UV-light exposure
F. Verheul et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins
Michael Helwig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
Giancarlo Comi et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients
Giulio Disanto et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
Charlotte Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Gray Matter Is Targeted in First-Attack Multiple Sclerosis
Steven E. Schutzer et al.
PLOS ONE (2013)
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis
Laura F. Dagley et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders
Mika Komori et al.
ANNALS OF NEUROLOGY (2012)
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
Ajit Singh Dhaunchak et al.
ANNALS OF NEUROLOGY (2012)
Treatment of neurological injury with thymosin β4
Daniel C. Morris et al.
THYMOSINS IN HEALTH AND DISEASE I (2012)
Contribution of Cerebrospinal Fluid Thymosin β4 Levels to the Clinical Differentiation of Creutzfeldt-Jakob Disease
Maria Le Pera et al.
ARCHIVES OF NEUROLOGY (2012)
Association between pathological and MRI findings in multiple sclerosis
Massimo Filippi et al.
LANCET NEUROLOGY (2012)
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
Dimitrios Davalos et al.
NATURE COMMUNICATIONS (2012)
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
Nikolaos A. Patsopoulos et al.
ANNALS OF NEUROLOGY (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome
W. Mai et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica
C. Tortorella et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Novel Aspects of Fibrin(ogen) Fragments during Inflammation
Carla Jennewein et al.
MOLECULAR MEDICINE (2011)
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry
C. E. Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?
Maria Trojano et al.
NEUROLOGIC CLINICS (2011)
Quantification of thymosin β4 in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Elena Urso et al.
ANALYTICAL BIOCHEMISTRY (2010)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease
Antonio Qualtieri et al.
EXPERT REVIEW OF PROTEOMICS (2010)
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
Niklas Mattsson et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
Marcel P. Stoop et al.
PLOS ONE (2010)
Downregulation of thymosin β4 in neural progenitor grafts promotes spinal cord regeneration
Cristiana Mollinari et al.
JOURNAL OF CELL SCIENCE (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
NEUROLOGICAL FUNCTIONAL RECOVERY AFTER THYMOSIN BETA4 TREATMENT IN MICE WITH EXPERIMENTAL AUTO ENCEPHALOMYELITIS
J. Zhang et al.
NEUROSCIENCE (2009)
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis
Niklas Mattsson et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Genomics and proteomics: role in the management of multiple sclerosis
L Kappos et al.
JOURNAL OF NEUROLOGY (2005)
Secretoneurin:: A new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system
R Fischer-Colbrie et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2005)
Plasminogen activators in multiple sclerosis lesions - Implications for the inflammatory response and axonal damage
D Gveric et al.
BRAIN (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Adjusting for multiple testing - when and how?
R Bender et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Heterogeneity of multiple sclerosis pathogenesis:: implications for diagnosis and therapy
H Lassmann et al.
TRENDS IN MOLECULAR MEDICINE (2001)
分享论文
